We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synpromics and GE Healthcare Unite

News   Jan 04, 2017 | Original Story From Synpromics, UK

 
Synpromics and GE Healthcare Unite
 
 
 

RELATED ARTICLES

New Study of HIV Vaccine Shows Promising Results Across Strains

News

Using the same RV 144 HIV vaccine employed in Thailand, a new study has evaluated whether the vaccine-induced immune responses to RV 144 are similar in a South African cohort.

READ MORE

Mutating Ebola Virus Protein Works as a Vaccine to Protect Animals From Infection

News

Creating mutations in a key Ebola virus protein that helps the deadly virus escape from the body's defenses can make the virus unable to produce sickness and activate protective immunity in the infected host, according to a study by the Institute for Biomedical Sciences at Georgia State University.

READ MORE

Phase 1 Trial Shows Cell Therapy Could Be a Feasible Treatment for Stroke Patients

News

Researchers have reported that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE